No clear answer
Cell therapy or transplant: reduce relapses and new lesions in primary progressive MS
primary progressive MS · Cell therapy or transplant
Trials have tried this, but none was a controlled phase 2 or 3 trial with a readable result.
- Trials
- 1
- Running now
- 0
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
How the verdict was reached
No result yet
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| Cell or transplant, phase 2 | Phase1|phase2 | 26 | 2013 | Paper found, not read | Not counted: tested as the comparator |
Counted: 0. Will count later: 0. Not counted: 1.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as No clear answer
Related hypotheses
- Cell therapy or transplant: prevent attacks in NMOSD
- Cell therapy or transplant: reduce relapses and new lesions in relapsing MS
- Cell therapy or transplant: reduce relapses and new lesions in relapsing and progressive MS
- Cell therapy or transplant: reduce relapses and new lesions in secondary progressive MS
- Cell therapy or transplant: reduce relapses and new lesions in MS (type not specified)
Assembled by software from public sources.